Variability and Function of Family 1 Uridine-5′-Diphosphate Glucuronosyltransferases (UGT1A)

REFERENCES

• G J Dutton. 1956. Uridine diphosphate glucuronic acid as glucuronyl donor in the synthesis of ester, aliphatic and steroid glucuronides. Biochem J 64:693–701.
   PubMed Web of Science ®Google Scholar
• G J Dutton, and I D Storey. 1953. The isolation of a compound of uridine diphosphate and glucuronic acid from liver. Biochem J 53:xxxvii–xxxviii.
   PubMed Web of Science ®Google Scholar
• G J Dutton. 1961. The mechanism of glucuronide formation. Biochem Pharmacol 6:65–71.
   PubMed Web of Science ®Google Scholar
• B Burchell, J Leakey, and G J Dutton. 1975. Relationship between activation of “detoxicating” enzymes in stored broken-cell preparations and in autolysing liver. Enzyme 20:156–164.
   PubMedGoogle Scholar
• G J Dutton, J E Leakey, and M R Pollard. 1981. Assays for UDPglucuronyltransferase activities. Methods Enzymol 77:383–391.
   PubMedGoogle Scholar
• A Gilbert, and P Lereboullet. 1901. La cholamae simple familiale. Sem Med 21:241–248.
   Google Scholar
• I M Arias. 1962. Chronic unconjugated hyperbilirubinemia without signs of overt hemolysis in adolescents and adults. J Clin Invest 41:2233–2245.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, and M P Manns. 2000. Jaundice, genes and promoters. J Hepatology 33:476–479.
   PubMed Web of Science ®Google Scholar
• J K Ritter, J M Crawford, and I S Owens. 1991. Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem 266:1043–1047.
   PubMed Web of Science ®Google Scholar
• J K Ritter, M T Yeatman, P Ferreira, and I S Owens. 1992. Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J Clin Invest 90:150–155.
   PubMed Web of Science ®Google Scholar
• Q H Gong, J W Cho, T Huang, C Potter, N Gholami, N K Basu, S Kubota, S Carvalho, M W Pennington, I S Owens, and N C Popescu. 2001. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357–368.
   PubMedGoogle Scholar
• R H Tukey, and C P Strassburg. 2000. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581–616.
   PubMed Web of Science ®Google Scholar
• R H Tukey, and C P Strassburg. 2001. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 59:405–414.
   PubMed Web of Science ®Google Scholar
• J K Ritter, F Chen, Y Y Sheen, H M Tran, S Kimura, M T Yeatman, and I S Owens. 1992. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267:3257–3261.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, S Kneip, J Topp, P Obermayer-Straub, A Barut, R H Tukey, and M P Manns. 2000. Polymorphic gene expression and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 275:36164–36171.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, M P Manns, and R H Tukey. 1998. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 273:8719–8726.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, N Nguyen, M P Manns, and R H Tukey. 1998. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 54:647–654.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, N Nguyen, M P Manns, and R H Tukey. 1999. UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 116:149–160.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, K Oldhafer, M P Manns, and R H Tukey. 1997. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 52:212–220.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, A Strassburg, N Nguyen, Q Li, M P Manns, and R H Tukey. 1999. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem J 338:489–498.
   PubMed Web of Science ®Google Scholar
• M Finel, X Li, D Gardner-Stephen, S Bratton, P I Mackenzie, and A Radominska-Pandya. 2005. Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity. J Pharmacol Exp Ther 315:1143–1149.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, A Strassburg, S Kneip, A Barut, R H Tukey, B Rodeck, and M P Manns. 2002. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259–265.
   PubMed Web of Science ®Google Scholar
• P I Mackenzie, I S Owens, B Burchell, K W Bock, A Bairoch, A Belanger, S Fournel-Gigleux, M Green, D W Hum, T Iyanagi, D Lancet, P Louisot, J Magdalou, J R Chowdhury, J K Ritter, H Schachter, T R Tephly, K F Tipton, and D W Nebert. 1997. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255–269.
   PubMedGoogle Scholar
• U Ehmer, A Vogel, J K Schutte, B Krone, M P Manns, and C P Strassburg. 2004. Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39:970–977.
   PubMed Web of Science ®Google Scholar
• M L Maitland, C Grimsley, H Kuttab-Boulos, D Witonsky, K E Kasza, L Yang, B A Roe, and A Di Rienzo. 2006. Comparative genomics analysis of human sequence variation in the UGT1A gene cluster. Pharmacogenomics J 6:52–62.
   PubMed Web of Science ®Google Scholar
• S S Thomas, S S Li, J W Lampe, J D Potter, and J Bigler. 2006. Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus. Hum Mutat 27:717.
   PubMed Web of Science ®Google Scholar
• C Kohle, B Mohrle, P A Munzel, M Schwab, D Wernet, O A Badary, and K W Bock. 2003. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol 65:1521–1527.
   PubMed Web of Science ®Google Scholar
• J W Lampe, J Bigler, N K Horner, and J D Potter. 1999. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 9:341–349.
   PubMedGoogle Scholar
• T O Lankisch, A Vogel, S Eilermann, A Fiebeler, B Krone, A Barut, M P Manns, and C P Strassburg. 2005. Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene. Mol Pharmacol 67:1732–1739.
   PubMed Web of Science ®Google Scholar
• C Guillemette, J K Ritter, D J Auyeung, F K Kessler, and D E Housman. 2000. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10:629–644.
   PubMedGoogle Scholar
• C P Strassburg, A Vogel, S Kneip, R H Tukey, and M P Manns. 2002. Polymorphisms of the UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50:851–856.
   PubMed Web of Science ®Google Scholar
• P J Bosma, J R Chowdhury, C Bakker, S Gantla, A de Boer, B A Oostra, D Lindhout, G N Tytgat, P L Jansen, R P Oude Elferink, N R Chowdhury, and et al 1995. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171–1175.
   PubMed Web of Science ®Google Scholar
• T J Erichsen, U Ehmer, S Kalthoff, T O Lankisch, T M Müller, P A Munzel, M P Manns, and C P Strassburg. 2008. Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene. Toxicol Appl Pharmacol 230:252–260.
   PubMed Web of Science ®Google Scholar
• D A Gardner-Stephen, and P I Mackenzie. 2007. Isolation of the UDP glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1 alpha. Drug Metab Dispos 35:116–120.
   PubMed Web of Science ®Google Scholar
• P J Bosma, J Seppen, B Goldhoorn, C Bakker, R P Oude Elferink, J R Chowdhury, N R Chowdhury, and P L Jansen. 1994. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960–17964.
   PubMed Web of Science ®Google Scholar
• J L Fang, and P Lazarus. 2004. Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant. Cancer Epidemiol Biomarkers Prev 13:102–109.
   PubMed Web of Science ®Google Scholar
• G Monaghan, M Ryan, R Seddon, R Hume, and B Burchell. 1996. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 347:578–581.
   PubMed Web of Science ®Google Scholar
• C Balram, K Sabapathy, G Fei, K S Khoo, and E J Lee. 2002. Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians. Pharmacogenetics 12:81–83.
   PubMedGoogle Scholar
• E Beutler, T Gelbart, and A Demina. 1998. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci USA 95:8170–8174.
   PubMed Web of Science ®Google Scholar
• Y Ando, M Chida, K Nakayama, H Saka, and T Kamataki. 1998. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 8:357–360.
   PubMedGoogle Scholar
• S Aono, Y Yamada, H Keino, N Hanada, T Nakagawa, Y Sasaoka, T Yazawa, H Sato, and O Koiwai. 1993. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 197:1239–1244.
   PubMed Web of Science ®Google Scholar
• S Aono, Y Adachi, E Uyama, Y Yamada, H Keino, T Nanno, O Koiwai, and H Sato. 1995. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 345:958–959.
   PubMed Web of Science ®Google Scholar
• W Udomuksorn, D J Elliot, B C Lewis, P I Mackenzie, K Yoovathaworn, and J O Miners. 2007. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates. Pharmacogenet Genomics 17:1017–1029.
   PubMed Web of Science ®Google Scholar
• J Sugatani, K Yamakawa, K Yoshinari, T Machida, H Takagi, M Mori, S Kakizaki, T Sueyoshi, M Negishi, and M Miwa. 2002. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun 292:492–497.
   PubMed Web of Science ®Google Scholar
• E Costa, E Vieira, M Martins, J Saraiva, E Cancela, M Costa, R Bauerle, T Freitas, J R Carvalho, E Santos-Silva, J Barbot, and R Dos Santos. 2006. Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes. Blood Cells Mol Dis 36:91–97.
   PubMed Web of Science ®Google Scholar
• S Farheen, S Sengupta, A Santra, S Pal, G K Dhali, M Chakravorty, P P Majumder, and A Chowdhury. 2006. Gilbert's syndrome: high frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. World J Gastroenterol 12:2269–2275.
   PubMed Web of Science ®Google Scholar
• K Sai, M Saeki, Y Saito, S Ozawa, N Katori, H Jinno, R Hasegawa, N Kaniwa, J Sawada, K Komamura, K Ueno, S Kamakura, M Kitakaze, Y Kitamura, N Kamatani, H Minami, A Ohtsu, K Shirao, T Yoshida, and N Saijo. 2004. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 75:501–515.
   PubMed Web of Science ®Google Scholar
• F Innocenti, C Grimsley, S Das, J Ramirez, C Cheng, H Kuttab-Boulos, M J Ratain, and A Di Rienzo. 2002. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Pharmacogenetics 12:725–733.
   PubMedGoogle Scholar
• T O Lankisch, U Moebius, M Wehmeier, G Behrens, M P Manns, R E Schmidt, and C P Strassburg. 2006. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Hepatology 44:1324–1332.
   PubMed Web of Science ®Google Scholar
• T O Lankisch, C Schulz, T Zwingers, T J Erichsen, M P Manns, V Heinemann, and C P Strassburg. 2008. Gilbert's syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer Epidemiol Biomarkers Prev 17:695–701.
   PubMed Web of Science ®Google Scholar
• B Mojarrabi, R Butler, and P I Mackenzie. 1996. cDNA cloning and characterization of the human UDP glucuronosyltransferase, UGT1A3. Biochem Biophys Res Commun 225:785–790.
   PubMed Web of Science ®Google Scholar
• M D Green, C D King, B Mojarrabi, P I Mackenzie, and T R Tephly. 1998. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507–512.
   PubMed Web of Science ®Google Scholar
• G E Kuehl, J W Lampe, J D Potter, and J Bigler. 2005. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos 33:1027–1035.
   PubMed Web of Science ®Google Scholar
• T Prueksaritanont, R Subramanian, X Fang, B Ma, Y Qiu, J H Lin, P G Pearson, and T A Baillie. 2002. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Drug Metab Dispos 30:505–512.
   PubMed Web of Science ®Google Scholar
• J Trottier, M Verreault, S Grepper, D Monte, J Belanger, J Kaeding, P Caron, T T Inaba, and O Barbier. 2006. Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver. Hepatology 44:1158–1170.
   PubMed Web of Science ®Google Scholar
• M Iwai, Y Maruo, M Ito, K Yamamoto, H Sato, and Y Takeuchi. 2004. Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 49:123–128.
   PubMed Web of Science ®Google Scholar
• N Kasai, T Sakaki, R Shinkyo, S Ikushiro, T Iyanagi, M Ohta, and K Inouye. 2005. Metabolism of 26,26,26,27,27,27-F6–1 alpha,23S,25-trihydroxyvitamin D3 by human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 33:102–107.
   PubMed Web of Science ®Google Scholar
• A Ghosal, N Hapangama, Y Yuan, J Achanfuo-Yeboah, R Iannucci, S Chowdhury, K Alton, J E Patrick, and S Zbaida. 2004. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dispos 32:314–320.
   PubMed Web of Science ®Google Scholar
• Z Yan, G W Caldwell, D Gauthier, G C Leo, J Mei, C Y Ho, W J Jones, J A Masucci, R W Tuman, R A GalemmoJr, and D L Johnson. 2006. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1, 2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases. Drug Metab Dispos 34:748–755.
   PubMed Web of Science ®Google Scholar
• B Caillier, J Lepine, J Tojcic, V Menard, L Perusse, A Belanger, O Barbier, and C Guillemette. 2007. A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3. Pharmacogenet Genomics 17:481–495.
   PubMed Web of Science ®Google Scholar
• M D Green, and T R Tephly. 1996. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos 24:356–363.
   PubMed Web of Science ®Google Scholar
• A Hiller, N Nguyen, C P Strassburg, Q Li, H Jainta, B Pechstein, P Ruus, J Engel, R H Tukey, and T Kronbach. 1999. Retigabine N-glucuronidation and its potential role in enterohepatic circulation. Drug Metab Dispos 27:605–612.
   PubMed Web of Science ®Google Scholar
• A Mori, Y Maruo, M Iwai, H Sato, and Y Takeuchi. 2005. UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation. Drug Metab Dispos 33:672–675.
   PubMed Web of Science ®Google Scholar
• A R Tricker. 2003. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 183:151–173.
   PubMed Web of Science ®Google Scholar
• D Sun, G Chen, R W Dellinger, K Duncan, J L Fang, and P Lazarus. 2006. Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants. Breast Cancer Res 8:R50.
   PubMed Web of Science ®Google Scholar
• D Wiener, D R Doerge, J L Fang, P Upadhyaya, and P Lazarus. 2004. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Drug Metab Dispos 32:72–79.
   PubMed Web of Science ®Google Scholar
• M Saeki, Y Saito, H Jinno, K Sai, A Hachisuka, N Kaniwa, S Ozawa, M Kawamoto, N Kamatani, K Shirao, H Minami, A Ohtsu, T Yoshida, N Saijo, K Komamura, T Kotake, H Morishita, S Kamakura, M Kitakaze, H Tomoike, and J Sawada. 2005. Genetic variations and haplotypes of UGT1A4 in a Japanese population. Drug Metab Pharmacokinet 20:144–151.
   PubMedGoogle Scholar
• D Harding, S Fournel-Gigleux, M R Jackson, and B Burchell. 1988. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc Natl Acad Sci USA 85:8381–8385.
   PubMed Web of Science ®Google Scholar
• S Krishnaswamy, S X Duan, L L Von Moltke, D J Greenblatt, and M H Court. 2003. Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Dispos 31:133–139.
   PubMed Web of Science ®Google Scholar
• K W Bock, A Forster, H Gschaidmeier, M Bruck, P Munzel, W Schareck, S Fournel-Gigleux, and B Burchell. 1993. Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809–1814.
   PubMed Web of Science ®Google Scholar
• K W Bock, and C Kohle. 2005. UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Methods Enzymol 400:57–75.
   PubMed Web of Science ®Google Scholar
• S Nagar, J J Zalatoris, and R L Blanchard. 2004. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14:487–499.
   PubMedGoogle Scholar
• D J Auyeung, F K Kessler, and J K Ritter. 2003. Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the aryl hydrocarbon receptor pathway. Mol Pharmacol 63:119–127.
   PubMed Web of Science ®Google Scholar
• P A Münzel, S Schmohl, H Heel, K Kölberer, B S Bock-Hennig, and K W Bock. 1999. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab Dispos 27:569–573.
   PubMed Web of Science ®Google Scholar
• J Ockenga, A Vogel, N Teich, V Keim, M P Manns, and C P Strassburg. 2003. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124:1802–1808.
   PubMed Web of Science ®Google Scholar
• J L Fang, F A Beland, D R Doerge, D Wiener, C Guillemette, M M Marques, and P Lazarus. 2002. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes. Cancer Res 62:1978–1986.
   PubMed Web of Science ®Google Scholar
• M A Malfatti, and J S Felton. 2004. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Chem Res Toxicol 17:1137–1144.
   PubMed Web of Science ®Google Scholar
• C La Vecchia, B D'Avanzo, L Airoldi, C Braga, and A Decarli. 1995. Nitrosamine intake and gastric cancer risk. Eur J Cancer Prev 4:469–474.
   PubMed Web of Science ®Google Scholar
• F F Kadlubar. Carcinogenic aromatic amine metabolism and DNA adduct detection in humansXenobiotics and Cancer: Implications for Chemical Carcinogenesis and Cancer Chemotherapy.L Ernster, H Esumi, Z Fujii, H V Gelboin, R Kato, and T Sugimura. Japan Scientific Press, Tokyo, 1991 339–359.
   Google Scholar
• H Esumi, H Ohgaki, E Kohzen, S Takayama, and T Sugimura. 1989. Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Jpn J Cancer Res 80:1176–1178.
   PubMedGoogle Scholar
• K Wakabayashi, M Nagao, H Esumi, and T Sugimura. Apr 1, 1992. Food-derived mutagens and carcinogens. Cancer Res 52 (7 Suppl):2092s–2098s.
   Web of Science ®Google Scholar
• H Kuper, A Tzonou, E Kaklamani, C C Hsieh, P Lagiou, H O Adami, D Trichopoulos, and S O Stuver. 2000. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85:498–502.
   PubMed Web of Science ®Google Scholar
• M Ciotti, N Basu, M Brangi, and I S Owens. 1999. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus. Biochem Biophys Res Commun 260:199–202.
   PubMed Web of Science ®Google Scholar
• K W Bock. 1991. Roles of UDP-glucuronosyltransferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 26:129–150.
   PubMed Web of Science ®Google Scholar
• M el Mouelhi, M S Didolkar, E G Elias, F P Guengerich, and F C Kauffman. 1987. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. Cancer Res 47:460–466.
   PubMed Web of Science ®Google Scholar
• G Fischer, A Schauer, H Hartmann, and K W Bock. 1985. Increased UDP-glucuronyltransferase in putative preneoplastic foci of human liver after long-term use of oral contraceptives. Naturwissenschaften 72:277–278.
   PubMedGoogle Scholar
• Z Hu, and P G Wells. 1994. Modulation of benzo[a]pyrene bioactivation by glucuronidation in lymphocytes and hepatic microsomes from rats with a hereditary deficiency in bilirubin UDP-glucuronosyltransferase. Toxicol Appl Pharmacol 127:306–313.
   PubMed Web of Science ®Google Scholar
• S A Nowell, J S Massengill, S Williams, A Radominska-Pandya, T R Tephly, Z Cheng, C P Strassburg, R H Tukey, S L MacLeod, N P Lang, and F F Kadlubar. 1999. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 20:1107–1114.
   PubMed Web of Science ®Google Scholar
• D S Vienneau, U DeBoni, and P G Wells. 1995. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Cancer Res 55:1045–1051.
   PubMed Web of Science ®Google Scholar
• Z Cheng, A Radominska-Pandya, and T R Tephly. 1998. Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. Arch Biochem Biophys 356:301–305.
   PubMed Web of Science ®Google Scholar
• Y H Huang, A Galijatovic, N Nguyen, D Geske, D Beaton, J Green, M Green, W H Peters, and R H Tukey. 2002. Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 12:287–297.
   PubMedGoogle Scholar
• D er Van, E M Logt, S M Bergevoet, H M Roelofs, Z Van Hooijdonk, R H Te Morsche, T Wobbes, J B De Kok, F M Nagengast, and W H Peters. 2004. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 19:19.
   Google Scholar
• M Verlaan, J P Drenth, K Truninger, M Koudova, H U Schulz, M Bargetzi, B Kunzli, H Friess, M Cerny, A Kage, O Landt, R H te Morsche, J Rosendahl, W Luck, R Nickel, J Halangk, M Becker, M MacekJr, J B Jansen, and H Witt. 2005. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet 42:e62.
   PubMed Web of Science ®Google Scholar
• P A Gregory, R H Lewinsky, D A Gardner-Stephen, and P I Mackenzie. 2004. Coordinate regulation of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 genes by hepatocyte nuclear factor 1alpha and the caudal-related homeodomain protein 2. Mol Pharmacol 65:953–963.
   PubMed Web of Science ®Google Scholar
• X Li, S Bratton, and A Radominska-Pandya. 2007. Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. Drug Metab Pharmacokinet 22:152–161.
   PubMed Web of Science ®Google Scholar
• T Ebner, R P Remmel, and B Burchell. 1993. Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol Pharmacol 43:649–654.
   PubMed Web of Science ®Google Scholar
• O Bernard, and C Guillemette. 2004. The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos 32:775–778.
   PubMed Web of Science ®Google Scholar
• M Shipkova, C P Strassburg, F Braun, F Streit, H J Grone, V W Armstrong, R H Tukey, M Oellerich, and E Wieland. 2001. Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Pharmacol 132:1027–1034.
   PubMed Web of Science ®Google Scholar
• H Girard, L Villeneuve, M H Court, L C Fortier, P Caron, Q Hao, L L von Moltke, D J Greenblatt, and C Guillemette. 2006. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver. Drug Metab Dispos 34:1220–1228.
   PubMed Web of Science ®Google Scholar
• C Albert, M Vallee, G Beaudry, A Belanger, and D W Hum. 1999. The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes. Endocrinology 140:3292–3302.
   PubMed Web of Science ®Google Scholar
• M F Yueh, N Nguyen, M Famourzadeh, C P Strassburg, Y Oda, F P Guengerich, and R H Tukey. 2001. The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Carcinogenesis 22:943–950.
   PubMed Web of Science ®Google Scholar
• L Villeneuve, H Girard, L C Fortier, J F Gagne, and C Guillemette. 2003. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 307:117–128.
   PubMed Web of Science ®Google Scholar
• M Saeki, Y Saito, H Jinno, K Sai, K Komamura, K Ueno, S Kamakura, M Kitakaze, K Shirao, H Minami, A Ohtsu, T Yoshida, N Saijo, S Ozawa, and J Sawada. 2003. Three novel single nucleotide polymorphisms in UGT1A9. Drug Metab Pharmacokinet 18:146–149.
   PubMedGoogle Scholar
• H Yamanaka, M Nakajima, M Katoh, Y Hara, O Tachibana, J Yamashita, H L McLeod, and T Yokoi. 2004. A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics 14:329–332.
   PubMedGoogle Scholar
• H Girard, M H Court, O Bernard, L C Fortier, L Villeneuve, Q Hao, D J Greenblatt, L L von Moltke, L Perussed, and C Guillemette. 2004. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 14:501–515.
   PubMedGoogle Scholar
• J Ramirez, W Liu, S Mirkov, A A Desai, P Chen, S Das, F Innocenti, and M J Ratain. 2007. Lack of association between common polymorphisms in UGT1A9 and gene expression and activity. Drug Metab Dispos 35:2149–2153.
   PubMed Web of Science ®Google Scholar
• S Baldelli, S Merlini, N Perico, A Nicastri, M Cortinovis, E Gotti, G Remuzzi, and D Cattaneo. 2007. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation. Pharmacogenomics 8:1127–1141.
   PubMed Web of Science ®Google Scholar
• O Barbier, H Girard, Y Inoue, H Duez, L Villeneuve, A Kamiya, J C Fruchart, C Guillemette, F J Gonzalez, and B Staels. 2005. Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha. Mol Pharmacol 67:241–249.
   PubMed Web of Science ®Google Scholar
• D A Gardner-Stephen, and P I Mackenzie. 2007. Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4alpha. Pharmacogenet Genomics 17:25–36.
   PubMed Web of Science ®Google Scholar
• C P Strassburg, M P Manns, and R H Tukey. 1997. Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res 57:2979–2985.
   PubMed Web of Science ®Google Scholar
• B Mojarrabi, and P I Mackenzie. 1998. Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon. Biochem Biophys Res Commun 247:704–709.
   PubMed Web of Science ®Google Scholar
• Z Zheng, J L Fang, and P Lazarus. 2002. Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 30:397–403.
   PubMed Web of Science ®Google Scholar
• A Starlard-Davenport, B Lyn-Cook, and A Radominska-Pandya. 2008. Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues. Steroids 73:611–620.
   PubMed Web of Science ®Google Scholar
• R W Dellinger, G Chen, A S Blevins-Primeau, J Krzeminski, S Amin, and P Lazarus. 2007. Glucuronidation of PhIP and N-OH-PhIP by UDP-glucuronosyltransferase 1A10. Carcinogenesis 28:2412–2418.
   PubMed Web of Science ®Google Scholar
• M G Boersma, H van der Woude, J Bogaards, S Boeren, J Vervoort, N H Cnubben, M L van Iersel, P J van Bladeren, and I M Rietjens. 2002. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 15:662–670.
   PubMed Web of Science ®Google Scholar
• H S Lee, H Y Ji, E J Park, and S Y Kim. 2007. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes. Xenobiotica 37:803–817.
   PubMed Web of Science ®Google Scholar
• B Mojarrabi, and P I Mackenzie. 1997. The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid. Biochem Biophys Res Commun 238:775–778.
   PubMed Web of Science ®Google Scholar
• N Takenaga, M Ishii, T Kamei, and T Yasumori. 2002. Structure-activity relationship in O-glucuronidation of indolocarbazole analogs. Drug Metab Dispos 30:494–497.
   PubMed Web of Science ®Google Scholar
• E J Jeong, Y Liu, H Lin, and M Hu. 2005. Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10. Drug Metab Dispos 33:785–794.
   PubMed Web of Science ®Google Scholar
• D C Kemp, P W Fan, and J C Stevens. 2002. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Drug Metab Dispos 30:694–700.
   PubMed Web of Science ®Google Scholar
• Y Watanabe, M Nakajima, and T Yokoi. 2002. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Drug Metab Dispos 30:1462–1469.
   PubMed Web of Science ®Google Scholar
• A Alonen, O Aitio, K Hakala, L Luukkanen, M Finel, and R Kostiainen. 2005. Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 33:657–663.
   PubMed Web of Science ®Google Scholar
• T Sten, S Qvisen, P Uutela, L Luukkanen, R Kostiainen, and M Finel. 2006. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10. Drug Metab Dispos 34:1488–1494.
   PubMed Web of Science ®Google Scholar
• A Starlard-Davenport, Y Xiong, S Bratton, A Gallus-Zawada, M Finel, and A Radominska-Pandya. 2007. Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10. Steroids 72:85–94.
   PubMed Web of Science ®Google Scholar
• A Elahi, J Bendaly, Z Zheng, J E Muscat, J P RichieJr, S P Schantz, and P Lazarus. 2003. Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer 98:872–880.
   PubMed Web of Science ®Google Scholar
• M Saeki, S Ozawa, Y Saito, H Jinno, T Hamaguchi, H Nokihara, Y Shimada, H Kunitoh, N Yamamoto, Y Ohe, Y Yamada, K Shirao, M Muto, K Mera, K Goto, H Ohmatsu, K Kubota, S Niho, R Kakinuma, H Minami, A Ohtsu, T Yoshida, N Saijo, and J Sawada. 2002. Three novel single nucleotide polymorphisms in UGT1A10. Drug Metab Pharmacokinet 17:488–490.
   PubMedGoogle Scholar
• I Martineau, A Tchernof, and A Belanger. 2004. Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10). Drug Metab Dispos 32:455–459.
   PubMed Web of Science ®Google Scholar
• R W Dellinger, J L Fang, G Chen, R Weinberg, and P Lazarus. 2006. Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform. Drug Metab Dispos 34:943–949.
   PubMed Web of Science ®Google Scholar
• P A Gregory, D A Gardner-Stephen, R H Lewinsky, K N Duncliffe, and P I Mackenzie. 2003. Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region. J Biol Chem 278:36107–36114.
   PubMed Web of Science ®Google Scholar
• A Starlard-Davenport, B Lyn-Cook, and A Radominska-Pandya. 2008. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids 73:139–147.
   PubMed Web of Science ®Google Scholar
• J H Yuan, Y Q Li, and X Y Yang. 2007. Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice. Pharmacology 80:269–278.
   PubMed Web of Science ®Google Scholar
• P D Berk, T F Blaschke, and J G Waggoner. 1972. Defective bromosulfophthalein clearance in patients with constitutional hepatic dysfunction (Gilbert's syndrome). Gastroenterology 63:472–481.
   PubMed Web of Science ®Google Scholar
• N Carulli, M Ponz deLeon, E Mauro, F Manenti, and A Ferrari. 1976. Alteration of drug metabolism in Gilbert's syndrome. Gut 17:581–587.
   PubMed Web of Science ®Google Scholar
• A F Macklon, R L Savage, and M D Rawlins. 1979. Gilbert's syndrome and drug metabolism. Clin Pharmacokinet 4:223–232.
   PubMed Web of Science ®Google Scholar
• K Kutz, H Kandler, R Gugler, and J Fevery. 1984. Effect of clofibrate on the metabolism of bilirubin, bromosulphophthalein and indocyanine green and on the biliary lipid composition in Gilbert's syndrome. Clin Sci (Lond) 66:389–397.
   PubMed Web of Science ®Google Scholar
• L Okolicsanyi, M Venuti, M Strazzabosco, A Biral, R Orlando, R M Iemmolo, G Nassuato, M Muraca, G Padrini, and P A Miglioli. 1985. Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses. Int J Clin Pharmacol Ther Toxicol 23:434–438.
   PubMedGoogle Scholar
• S Chouinard, M Tessier, G Vernouillet, S Gauthier, F Labrie, O Barbier, and A Belanger. 2005. Inactivation of the pure antiestrogen Fulvestrant and other synthetic estrogen molecules by UGT1A enzymes expressed in the breast tissue. Mol Pharmacol 69:908–920.
   PubMed Web of Science ®Google Scholar
• C D King, G R Rios, M D Green, P I MacKenzie, and T R Tephly. 1997. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab Dispos 25:251–255.
   PubMed Web of Science ®Google Scholar
• B W Ogilvie, D Zhang, W Li, A D Rodrigues, A E Gipson, J Holsapple, P Toren, and A Parkinson. 2006. Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of cyp2c8: implications for drug-drug interactions. Drug Metab Dispos 34:191–197.
   PubMed Web of Science ®Google Scholar
• F Innocenti, E E Vokes, and M J Ratain. 2006. Irinogenetics: what is the right star?. J Clin Oncol 24:2221–2224.
   PubMed Web of Science ®Google Scholar
• Y Ando, H Saka, G Asai, S Sugiura, K Shimokata, and T Kamataki. 1998. UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan. Ann Oncol 9:845–847.
   PubMed Web of Science ®Google Scholar
• J Y Douillard, D Cunningham, A D Roth, M Navarro, R D James, P Karasek, P Jandik, T Iveson, J Carmichael, M Alakl, G Gruia, L Awad, and P Rougier. 2000. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047.
   PubMed Web of Science ®Google Scholar
• G Folprecht, and C H Kohne. 2004. The role of new agents in the treatment of colorectal cancer. Oncology 66:1–17.
   PubMed Web of Science ®Google Scholar
• Y Kawato, M Aonuma, Y Hirota, H Kuga, and K Sato. 1991. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51:4187–4191.
   PubMed Web of Science ®Google Scholar
• R H Tukey, C P Strassburg, and P I Mackenzie. 2002. Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol Pharmacol 62:446–450.
   PubMed Web of Science ®Google Scholar
• F Innocenti, and M J Ratain. 2003. Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. Oncology (Williston Park) 17:52–55.
   PubMedGoogle Scholar
• J F Gagne, V Montminy, P Belanger, K Journault, G Gaucher, and C Guillemette. 2002. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 62:608–617.
   PubMed Web of Science ®Google Scholar
• F Innocenti, S D Undevia, L Iyer, P X Chen, S Das, M Kocherginsky, T Karrison, L Janisch, J Ramirez, C M Rudin, E E Vokes, and M J Ratain. 2004. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 22:1382–1388.
   PubMed Web of Science ®Google Scholar
• L Iyer, C D King, P F Whitington, M D Green, S K Roy, T R Tephly, B L Coffman, and M J Ratain. 1998. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest 101:847–854.
   PubMed Web of Science ®Google Scholar
• E Rouits, M Boisdron-Celle, A Dumont, O Guerin, A Morel, and E Gamelin. 2004. Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients. Clin Cancer Res 10:5151–5159.
   PubMed Web of Science ®Google Scholar
• E Marcuello, A Altes, A Menoyo, E Del Rio, M Gomez-Pardo, and M Baiget. 2004. UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer. Br J Cancer 91:678–682.
   PubMed Web of Science ®Google Scholar
• L E Carlini, N J Meropol, J Bever, M L Andria, T Hill, P Gold, A Rogatko, H Wang, and R L Blanchard. 2005. UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clin Cancer Res 11:1226–1236.
   PubMed Web of Science ®Google Scholar
• M N Tallman, K Miles, F Kessler, J Neilson, X Tian, J K Ritter, and P C Smith. 2007. The contribution of intestinal UDP-glucuronosyltrasferases in modulating Sn-38 induced gastrointestinal toxicity in rats. J Pharmacol Exp Ther 320:29–37.
   PubMed Web of Science ®Google Scholar
• M Rotger, P Taffe, G Bleiber, H F Gunthard, H Furrer, P Vernazza, H Drechsler, E Bernasconi, M Rickenbach, and A Telenti. 2005. Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. J Infect Dis 192:1381–1386.
   PubMed Web of Science ®Google Scholar
• S D Zucker, X Qin, S D Rouster, F Yu, R M Green, P Keshavan, J Feinberg, and K E Sherman. 2001. Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci USA 98:12671–12676.
   PubMed Web of Science ®Google Scholar
• D Zhang, T J Chando, D W Everett, C J Patten, S S Dehal, and W G Humphreys. 2005. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug Metab Dispos 33:1729–1739.
   PubMed Web of Science ®Google Scholar
• P J Bosma, J R Chowdhury, T J Huang, P Lahiri, R P Elferink, H H Van Es, M Lederstein, P F Whitington, P L Jansen, and N R Chowdhury. 1992. Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I. FASEB J 6:2859–2863.
   PubMed Web of Science ®Google Scholar
• P J Bosma, N R Chowdhury, B G Goldhoorn, M H Hofker, R P Oude Elferink, P L Jansen, and J R Chowdhury. 1992. Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Hepatology 15:941–947.
   PubMed Web of Science ®Google Scholar
• T Iyanagi. 1991. Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat, (Gunn rat). J Biol Chem 266:24048–24052.
   PubMed Web of Science ®Google Scholar
• P J Bosma, B Goldhoorn, R P Oude Elferink, M Sinaasappel, B A Oostra, and P L Jansen. 1993. A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II. Gastroenterology 105:216–220.
   PubMed Web of Science ®Google Scholar
• J K Ritter, M T Yeatman, C Kaiser, B Gridelli, and I S Owens. 1993. A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase. J Biol Chem 268:23573–23579.
   PubMed Web of Science ®Google Scholar
• J Kapitulnik, and F J Gonzalez. 1993. Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol 43:722–725.
   PubMed Web of Science ®Google Scholar
• J Kapitulnik, J P Hardwick, J D Ostrow, C C Webster, S S Park, and H V Gelboin. 1987. Increase in a specific cytochrome P-450 isoenzyme in the liver of congenitally jaundiced Gunn rats. Biochem J 242:297–300.
   PubMed Web of Science ®Google Scholar
• K S Tang, H F Chiu, H H Chen, H L Eng, C J Tsai, H C Teng, and C S Huang. 2005. Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol 11:3250–3254.
   PubMed Web of Science ®Google Scholar
• S D Zucker, P S Horn, and K E Sherman. 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 40:827–835.
   PubMed Web of Science ®Google Scholar
• I Rigato, J D Ostrow, and C Tiribelli. 2005. Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med 11:277–283.
   PubMed Web of Science ®Google Scholar
• J Bigler, J Whitton, J W Lampe, L Fosdick, R M Bostick, and J D Potter. 2001. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 61:3566–3569.
   PubMed Web of Science ®Google Scholar
• A T Chan, G J Tranah, E L Giovannucci, D J Hunter, and C S Fuchs. 2005. Genetic variants in the UGT1A6 enzyme, aspirin use and the risk of colorectal adenoma. J Natl Cancer Inst 97:457–460.
   PubMed Web of Science ®Google Scholar
• R A Hubner, K R Muir, J F Liu, R F Logan, M Grainge, N Armitage, V Shepherd, S Popat, and R S Houlston. 2006. Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clin Cancer Res 12:6585–6589.
   PubMed Web of Science ®Google Scholar
• L M Butler, Y Duguay, R C Millikan, R Sinha, J F Gagne, R S Sandler, and C Guillemette. 2005. Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14:1626–1632.
   PubMed Web of Science ®Google Scholar
• K Chen, M Jin, Y Zhu, Q Jiang, W Yu, X Ma, and K Yao. 2006. Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population. J Gastroenterol Hepatol 21:1036–1041.
   PubMed Web of Science ®Google Scholar
• C Guillemette, R C Millikan, B Newman, and D E Housman. 2000. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 60:950–956.
   PubMed Web of Science ®Google Scholar
• C Guillemette, I De Vivo, S E Hankinson, C A Haiman, D Spiegelman, D E Housman, and D J Hunter. 2001. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 10:711–714.
   PubMed Web of Science ®Google Scholar
• R Sparks, C M Ulrich, J Bigler, S S Tworoger, Y Yasui, K B Rajan, P Porter, F Z Stanczyk, R Ballard-Barbash, X Yuan, M G Lin, L McVarish, E J Aiello, and A McTiernan. 2004. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 6:R488–R498.
   PubMed Web of Science ®Google Scholar
• O J Adegoke, X O Shu, Y T Gao, Q Cai, J Breyer, J Smith, and W Zheng. 2004. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat 85:239–245.
   PubMed Web of Science ®Google Scholar
• A Vogel, S Kneip, S Barut, U Ehmer, R H Tukey, M P Manns, and C P Strassburg. 2001. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121:1136–1144.
   PubMed Web of Science ®Google Scholar
• Y Wang, N Kato, Y Hoshida, M Otsuka, H Taniguchi, M Moriyama, S Shiina, T Kawabe, Y M Ito, and M Omata. 2004. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection. Clin Cancer Res 10:2441–2446.
   PubMed Web of Science ®Google Scholar
• C S Tseng, K S Tang, H W Lo, C G Ker, H C Teng, and C S Huang. 2005. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol 100:1758–1763.
   PubMed Web of Science ®Google Scholar
• I Stucker, M A Loriot, G N'Koutchou, S Cenee, L Bodin, C Mulot, M Gelu-Simeon, L Pelletier, J P Bronowicki, F Degos, P Beaune, P Laurent-Puig, D Hemon, J C Trinchet, and G Pelletier. 2007. UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?. BMC Cancer 7:214.
   PubMed Web of Science ®Google Scholar
• S Y Kong, C S Ki, B C Yoo, and J W Kim. 2008. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers. Cancer Sci 99:340–344.
   PubMed Web of Science ®Google Scholar
• A Piepoli, A Gentile, M R Valvano, D Barana, C Oliani, R Cotugno, M Quitadamo, A Andriulli, and F Perri. 2006. Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J Gastroenterol 12:6343–6348.
   PubMed Web of Science ®Google Scholar
• R H te Morsche, J P Drenth, K Truninger, H U Schulz, A Kage, O Landt, M Verlaan, J Rosendahl, M MacekJr, J B Jansen, and H Witt. 2008. UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls. Pharmacogenomics J 8:34–41.
   PubMed Web of Science ®Google Scholar
• Y Emi, S Ikushiro, and T Iyanagi. 1996. Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J Biol Chem 271:3952–3958.
   PubMed Web of Science ®Google Scholar
• J K Ritter, F K Kessler, M T Thompson, A D Grove, D J Auyeung, and R A Fisher. 1999. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology 30:476–484.
   PubMed Web of Science ®Google Scholar
• T Usui, T Kuno, H Ueyama, I Ohkubo, and T Mizutani. 2006. Proximal HNF1 element is essential for the induction of human UDP-glucuronosyltransferase 1A1 by glucocorticoid receptor. Biochem Pharmacol 71:693–701.
   PubMed Web of Science ®Google Scholar
• M F Yueh, and R H Tukey. 2007. Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice. J Biol Chem 282:8749–8758.
   PubMed Web of Science ®Google Scholar
• J Sugatani, H Kojima, A Ueda, S Kakizaki, K Yoshinari, Q H Gong, I S Owens, M Negishi, and T Sueyoshi. 2001. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33:1232–1238.
   PubMed Web of Science ®Google Scholar
• E Ellis, M Wagner, F Lammert, A Nemeth, J Gumhold, C P Strassburg, C Kylander, D Katsika, M Trauner, C Einarsson, and H U Marschall. 2006. Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin. J Hepatol 44:243–245.
   PubMed Web of Science ®Google Scholar
• J F Martin, J M Vierling, A W Wolkoff, B F Scharschmidt, J Vergalla, J G Waggoner, and P D Berk. 1976. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology 70:385–391.
   PubMed Web of Science ®Google Scholar
• N Moghrabi, D J Clarke, M Boxer, and B Burchell. 1993. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics 18:171–173.
   PubMed Web of Science ®Google Scholar
• N Moghrabi, D J Clarke, B Burchell, and M Boxer. 1993. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis. Am J Hum Genet 53:722–729.
   PubMed Web of Science ®Google Scholar
• L T Erps, J K Ritter, J H Hersh, D Blossom, N C Martin, and I S Owens. 1994. Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J Clin Invest 93:564–570.
   PubMed Web of Science ®Google Scholar
• P Labrune, A Myara, M Hadchouel, F Ronchi, O Bernard, F Trivin, N R Chowdhury, J R Chowdhury, A Munnich, and M Odievre. 1994. Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. Hum Genet 94:693–697.
   PubMed Web of Science ®Google Scholar
• J Seppen, P J Bosma, B G Goldhoorn, C T Bakker, J R Chowdhury, N R Chowdhury, P L Jansen, and R P Oude Elferink. 1994. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 94:2385–2391.
   PubMed Web of Science ®Google Scholar
• S Aono, Y Yamada, H Keino, Y Sasaoka, T Nakagawa, S Onishi, S Mimura, O Koiwai, and H Sato. 1994. A new type of defect in the gene for bilirubin uridine 5′-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I. Pediatr Res 35:629–632.
   PubMed Web of Science ®Google Scholar
• R Sutomo, V Laosombat, A H Sadewa, N Yokoyama, H Nakamura, M Matsuo, and H Nishio. 2002. Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. Pediatr Int 44:427–432.
   PubMed Web of Science ®Google Scholar
• M Saeki, Y Saito, H Jinno, K Sai, S Ozawa, K Kurose, N Kaniwa, K Komamura, T Kotake, H Morishita, S Kamakura, M Kitakaze, H Tomoike, K Shirao, T Tamura, N Yamamoto, H Kunitoh, T Hamaguchi, T Yoshida, K Kubota, A Ohtsu, M Muto, H Minami, N Saijo, N Kamatani, and J I Sawada. 2006. Haplotype structures of the UGT1A gene complex in a Japanese population. Pharmacogenomics J 6:63–75.
   PubMed Web of Science ®Google Scholar
• S Krishnaswamy, Q Hao, A Al-Rohaimi, L M Hesse, L L von Moltke, D J Greenblatt, and M H Court. 2005. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5′-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation. J Pharmacol Exp Ther 313:1331–1339.
   PubMed Web of Science ®Google Scholar
• M Saeki, Y Saito, H Jinno, K Sai, N Kaniwa, S Ozawa, K Komamura, T Kotake, H Morishita, S Kamakura, M Kitakaze, H Tomoike, K Shirao, H Minami, A Ohtsu, T Yoshida, N Saijo, N Kamatani, and J Sawada. 2005. Genetic polymorphisms of UGT1A6 in a Japanese population. Drug Metab Pharmacokinet 20:85–90.
   PubMedGoogle Scholar
• S Krishnaswamy, Q Hao, A Al-Rohaimi, L M Hesse, L L von Moltke, D J Greenblatt, and M H Court. 2005. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). J Pharmacol Exp Ther 313:1340–1346.
   PubMed Web of Science ®Google Scholar
• M Ciotti, A Marrone, C Potter, and I S Owens. 1997. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7:485–495.
   PubMedGoogle Scholar
• K Fujita, Y Ando, F Nagashima, W Yamamoto, H Endo, K Kodama, K Araki, T Miya, M Narabayashi, and Y Sasaki. 2006. Novel single nucleotide polymorphism of UGT1A7 gene in Japanese. Drug Metab Pharmacokinet 21:75–78.
   PubMed Web of Science ®Google Scholar
• T Ebner, and B Burchell. 1993. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos 21:50–55.
   PubMed Web of Science ®Google Scholar
• K Inoue, M Miura, S Satoh, H Kagaya, M Saito, T Habuchi, and T Suzuki. 2007. Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Ther Drug Monit 29:299–304.
   PubMed Web of Science ®Google Scholar
• E Sandanaraj, S R Jada, X Shu, R Lim, S C Lee, Q Zhou, S Zhou, B C Goh, and B Chowbay. 2008. Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients. Pharmacogenomics J 8:174–185.
   PubMed Web of Science ®Google Scholar
• K Fujita, Y Ando, F Nagashima, W Yamamoto, H Endo, K Kodama, K Araki, T Miya, M Narabayashi, and Y Sasaki. 2006. Novel single nucleotide polymorphism of UGT1A9 gene in Japanese. Drug Metab Pharmacokinet 21:79–81.
   PubMed Web of Science ®Google Scholar
• H Jinno, M Saeki, Y Saito, T Tanaka-Kagawa, N Hanioka, K Sai, N Kaniwa, M Ando, K Shirao, H Minami, A Ohtsu, T Yoshida, N Saijo, S Ozawa, and J Sawada. 2003. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. J Pharmacol Exp Ther 306:688–693.
   PubMed Web of Science ®Google Scholar
• H Jinno, M Saeki, T Tanaka-Kagawa, N Hanioka, Y Saito, S Ozawa, M Ando, K Shirao, H Minami, A Ohtsu, T Yoshida, and N J S Saijo. 2003. Functional characterization of wild-type and variant (T202I and M59I) human UDP-glucuronosyltransferase 1A10. Drug Metabol Dispos 31:528–531.
   PubMed Web of Science ®Google Scholar
• C D King, M D Green, G R Rios, B L Coffman, I S Owens, W P Bishop, and T R Tephly. 1996. The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch Biochem Biophys 332:92–100.
   PubMed Web of Science ®Google Scholar
• Y Duguay, M McGrath, J Lepine, J F Gagne, S E Hankinson, G A Colditz, D J Hunter, M Plante, B Tetu, A Belanger, C Guillemette, and I De Vivo. 2004. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res 64:1202–1207.
   PubMed Web of Science ®Google Scholar
• L E McGreavey, F Turner, G Smith, K Boylan, D Timothy Bishop, D Forman, C Roland Wolf, and J H Barrett. 2005. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma. Pharmacogenet Genomics 15:713–721.
   PubMed Web of Science ®Google Scholar
• K S Tang, C M Lee, H C Teng, M J Huang, and C S Huang. 2008. UDP-glucuronosyltransferase 1A7 polymorphisms are associated with liver cirrhosis. Biochem Biophys Res Commun 366:643–648.
   PubMed Web of Science ®Google Scholar
• A Vogel, J Ockenga, U Ehmer, A Barut, F-J Kramer, R H Tukey, M P Manns, and C P Strassburg. 2002. Polymorphisms of the carcinogen detoxifying UDP-glucuronosyltransferase UGT1A7 in proximal digestive tract cancer. Z Gastroenterol 40:497–502.
   PubMed Web of Science ®Google Scholar
• J Araki, Y Kobayashi, M Iwasa, N Urawa, E C Gabazza, O Taguchi, M Kaito, and Y Adachi. 2005. Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. Eur J Cancer 41:2360–2365.
   PubMed Web of Science ®Google Scholar
• Z Zheng, J Y Park, C Guillemette, S P Schantz, and P Lazarus. 2001. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 93:1411–1418.
   PubMed Web of Science ®Google Scholar
• E Meulengracht. 1939. Icterus intermittens juvenilis. Klin Wochenschrift 18:118–125.
   Google Scholar